InsidersTradesSigma
基于 7 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Traversa Sergio. Director active across 1 company, notably Relmada Therapeutics, INC.. Cumulatively, 10 filings have been published. Split: 9 buys · 0 sell. Total volume traded: €1.8m. Activity tracked since 30 June 2022. The latest transaction was disclosed on 9 September 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
TRAVERSA SERGIO is a declarant with 8 filings in total. In the 8 sampled recent filings, all linked to Relmada Therapeutics, INC. (XNAS) where he is Chief Executive Officer, buys amount to EUR 1085152 and sells to EUR 0, with a period running from 2022-07-05 to 2025-12-16. The modal transaction nature is Acquisition.